Authors
Loading...
Phase II trial demonstrates a treatment protocol for early Hodgkin Lymphoma, suggesting the efficacy of monitoring circulating tumor DNA for improved outcomes.
Picardi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: